FibroBiologics (FBLG) Competitors $0.88 +0.01 (+1.14%) As of 10:08 AM Eastern This is a fair market value price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrendsBuy This Stock FBLG vs. NKTX, CGEN, OGI, TLSA, GLSI, DERM, MCRB, ALEC, ENTA, and EPRXShould you be buying FibroBiologics stock or one of its competitors? The main competitors of FibroBiologics include Nkarta (NKTX), Compugen (CGEN), Organigram (OGI), Tiziana Life Sciences (TLSA), Greenwich LifeSciences (GLSI), Journey Medical (DERM), Seres Therapeutics (MCRB), Alector (ALEC), Enanta Pharmaceuticals (ENTA), and Eupraxia Pharmaceuticals (EPRX). These companies are all part of the "pharmaceutical products" industry. FibroBiologics vs. Nkarta Compugen Organigram Tiziana Life Sciences Greenwich LifeSciences Journey Medical Seres Therapeutics Alector Enanta Pharmaceuticals Eupraxia Pharmaceuticals Nkarta (NASDAQ:NKTX) and FibroBiologics (NASDAQ:FBLG) are both small-cap medical companies, but which is the superior business? We will compare the two businesses based on the strength of their community ranking, risk, institutional ownership, earnings, dividends, media sentiment, valuation, profitability and analyst recommendations. Do insiders & institutionals believe in NKTX or FBLG? 80.5% of Nkarta shares are held by institutional investors. 8.7% of Nkarta shares are held by insiders. Comparatively, 20.8% of FibroBiologics shares are held by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock is poised for long-term growth. Does the MarketBeat Community prefer NKTX or FBLG? Nkarta received 51 more outperform votes than FibroBiologics when rated by MarketBeat users. However, 100.00% of users gave FibroBiologics an outperform vote while only 77.78% of users gave Nkarta an outperform vote. CompanyUnderperformOutperformNkartaOutperform Votes6377.78% Underperform Votes1822.22% FibroBiologicsOutperform Votes12100.00% Underperform VotesNo Votes Does the media favor NKTX or FBLG? In the previous week, Nkarta had 11 more articles in the media than FibroBiologics. MarketBeat recorded 27 mentions for Nkarta and 16 mentions for FibroBiologics. Nkarta's average media sentiment score of 0.61 beat FibroBiologics' score of 0.52 indicating that Nkarta is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Nkarta 6 Very Positive mention(s) 1 Positive mention(s) 8 Neutral mention(s) 1 Negative mention(s) 0 Very Negative mention(s) Positive FibroBiologics 0 Very Positive mention(s) 0 Positive mention(s) 8 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Do analysts recommend NKTX or FBLG? Nkarta presently has a consensus price target of $14.86, suggesting a potential upside of 789.12%. FibroBiologics has a consensus price target of $13.00, suggesting a potential upside of 1,368.93%. Given FibroBiologics' higher possible upside, analysts clearly believe FibroBiologics is more favorable than Nkarta.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Nkarta 0 Sell rating(s) 0 Hold rating(s) 6 Buy rating(s) 2 Strong Buy rating(s) 3.25FibroBiologics 0 Sell rating(s) 0 Hold rating(s) 4 Buy rating(s) 1 Strong Buy rating(s) 3.20 Is NKTX or FBLG more profitable? FibroBiologics' return on equity of 0.00% beat Nkarta's return on equity.Company Net Margins Return on Equity Return on Assets NkartaN/A -27.13% -21.67% FibroBiologics N/A N/A -225.34% Which has preferable earnings & valuation, NKTX or FBLG? CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioNkartaN/AN/A-$117.50M-$1.66-1.01FibroBiologicsN/AN/A-$16.49MN/AN/A Which has more volatility & risk, NKTX or FBLG? Nkarta has a beta of 0.83, meaning that its share price is 17% less volatile than the S&P 500. Comparatively, FibroBiologics has a beta of -0.7, meaning that its share price is 170% less volatile than the S&P 500. SummaryNkarta beats FibroBiologics on 9 of the 14 factors compared between the two stocks. Remove Ads Get FibroBiologics News Delivered to You Automatically Sign up to receive the latest news and ratings for FBLG and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart FBLG vs. The Competition Export to ExcelMetricFibroBiologicsPharmaceutical IndustryMedical SectorNASDAQ ExchangeMarket Cap$32.66M$6.56B$5.40B$7.28BDividend YieldN/A2.85%4.87%4.05%P/E RatioN/A6.8522.8817.61Price / SalesN/A194.91357.3086.64Price / CashN/A65.6738.1634.64Price / Book22.135.746.323.86Net Income-$16.49M$142.37M$3.21B$247.18M7 Day Performance-6.84%-9.71%-6.89%-6.27%1 Month Performance-27.76%-12.66%-1.87%-8.87%1 Year Performance-92.24%-16.65%4.62%-6.18% FibroBiologics Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)FBLGFibroBiologics1.8601 of 5 stars$0.89+1.1%$13.00+1,368.9%-92.2%$32.66MN/A0.0010Earnings ReportAnalyst ForecastAnalyst RevisionNews CoverageNKTXNkarta2.5572 of 5 stars$1.84-8.0%$14.86+707.5%-82.0%$130.56MN/A-0.98140Gap DownCGENCompugen1.2449 of 5 stars$1.46-4.6%$4.00+174.0%-42.0%$130.29M$27.86M73.0070Gap DownOGIOrganigram0.5444 of 5 stars$1.01-1.9%N/A-57.2%$127.52M$166.12M-2.66860TLSATiziana Life Sciences0.7571 of 5 stars$1.08-3.6%N/A+133.7%$126.20MN/A0.008Gap DownGLSIGreenwich LifeSciences1.6496 of 5 stars$9.54-6.7%$38.00+298.3%-47.8%$125.40MN/A-11.923News CoverageGap DownDERMJourney Medical2.3592 of 5 stars$5.90-3.4%$9.67+63.8%+92.7%$123.25M$56.13M-6.2890MCRBSeres Therapeutics3.1506 of 5 stars$0.70-2.9%$4.00+471.3%-5.2%$122.07M$126.33M-3.04330Positive NewsGap DownALECAlector3.7225 of 5 stars$1.23-4.7%$3.50+184.6%-81.5%$121.88M$100.56M-0.72270Gap DownENTAEnanta Pharmaceuticals3.7315 of 5 stars$5.52-3.3%$17.25+212.5%-69.8%$117.76M$66.59M-1.12160EPRXEupraxia Pharmaceuticals1.8816 of 5 stars$3.28-3.1%$10.50+220.6%N/A$116.74MN/A-4.5529Upcoming EarningsGap Up Remove Ads Related Companies and Tools Related Companies NKTX Competitors CGEN Competitors OGI Competitors TLSA Competitors GLSI Competitors DERM Competitors MCRB Competitors ALEC Competitors ENTA Competitors EPRX Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:FBLG) was last updated on 4/4/2025 by MarketBeat.com Staff From Our PartnersTrump Allies Confirm Exec Order 14024 Triggers Dollar CollapseExecutive Order 14024 is paving the way for irreversible damage to the dollar's value—threatening your wealth,...Priority Gold | SponsoredTrump Orders 'National Digital Asset Stockpile'‘Digital Asset Reserve’ for THIS Coin??? Get all the details before this story gains even more tractionCrypto 101 Media | SponsoredURGENT: Someone's Moving Gold Out of London...People who don’t understand the gold market are about to lose a lot of money. Unfortunately, most so-called “g...Golden Portfolio | SponsoredTrump’s Secret WeaponPlease don't wait—this is your moment to take action. Download your Wealth Protection Guide now, claim your fr...American Alternative | SponsoredCollect $7k per month from Tesla’s SECRET dividendTesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...Investors Alley | SponsoredDOGE Social Security bombshell?Elon Musk just dropped another bombshell... He revealed his DOGE organization has been taking aim at Social...Altimetry | SponsoredUrgent Bitcoin alert for RIGHT NOWFormer billion-dollar hedge fund manager Larry Benedict has released the most incredible presentation of his 4...Brownstone Research | SponsoredCrypto’s crashing…but we’re still profitingMost traders are panicking right now. Bitcoin’s dropping. Altcoins are bleeding. The stock market’s a mess....Crypto Swap Profits | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding FibroBiologics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share FibroBiologics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
